Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Current research status Retatrutide is currently in Phase 3 clinical trials, with Eli Lilly conducting multiple large-scale studies
In the acute cases of neuropathy, dose of 1500 mcg per day can be safely taken
Use of MOUNJARO for this indication is supported by a 30-week, randomized, double-blind, placebo-controlled trial with a 22-week open label extension in 99 pediatric patients [see Clinical Studies (14.5)]
Well help you uncover the root cause, and create a clear, personalized plan forward
Blog Categories Table of Contents Product Recommendations
US$ 22.27
US$ 26.87
